MEDIPOST Co., Ltd. (KOSDAQ:078160)

MEDIPOST Revenue

MEDIPOST had revenue of 18.78B KRW in the quarter ending June 30, 2026, with 5.32% growth. This brings the company's total for the last twelve months to 74.84B, up 3.70% year-over-year. In the year 2025, MEDIPOST had annual revenue of 73.66B with 4.25% growth. That makes MEDIPOST the 27,138th largest company in the world by revenue and 1,631st in South Korea.

• Revenue (ttm): 74.84B
• Revenue Growth: +3.70%
• P/S Ratio: 4.22
• Revenue / Employee: 232.43M
• Employees: 322
• Market Cap: 322.85B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Cord Blood Division 41.50B 54.0%
• Cell Therapy Sales Division 19.46B 25.3%
• Health Function Food Sector 10.42B 13.5%
• Others 5.51B 7.2%

By Geography

Chart

• South Korea 73.63B 100.0%
• Export 22.31M 0.0%

Fiscal year ended Dec 31, 2025 See the full MEDIPOST breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	73.66B	3.00B	4.25%
Dec 31, 2024	70.66B	2.01B	2.93%
Dec 31, 2023	68.64B	4.44B	6.92%
Dec 31, 2022	64.20B	9.34B	17.03%
Dec 31, 2021	54.86B	6.23B	12.82%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 2, 2026

Data Sources Report a data error